Dr. Melissa Pam Sirichotiratana, MD

Dr. Sirichotiratana practices at Dermatology Specialists Inc in Oceanside, California.

Dr. Sirichotiratana's NPI, 1689961468, was assigned on June 30, 2011. Dr. Sirichotiratana graduated from Loma Linda University School Of Medicine in 2011. Dr. Sirichotiratana's California license number on file is A137981.

Dr. Sirichotiratana's primary practice is Dermatology Specialists Inc, at 3629 Vista Way, Oceanside, CA 92056 in San Diego County. The practice phone is (760) 828-9200.

Dr. Sirichotiratana's primary practice is Dermatology Specialists Inc in Oceanside, California. The medical group on file is Dermatology Specialists, Inc. Dmand AI also links Dr. Sirichotiratana to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sirichotiratana practices. Vendor and product names are available with a free account.

Dermatology is Dr. Sirichotiratana's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Sirichotiratana is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Sirichotiratana's licenses on file in 2 states: California and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, hives and itchy rashes among the conditions Dr. Sirichotiratana treats.

CMS data shows 6,678 Medicare services from Dr. Sirichotiratana across 19 procedure codes in 2024, for 935 Medicare patients. Medicare paid $278,682 for them. Every service was in an office.

CMS counts 935 Medicare patients who saw Dr. Sirichotiratana in 2024. The largest group is 65 to 74, with 486 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sirichotiratana's median patient age at 62, with 57% women.

In 2024, Dr. Sirichotiratana wrote 700 Medicare Part D claims for 374 patients. 90% of them were for generic drugs. CMS names the drug for 606 of them, across 14 drugs with 11 or more claims each, at $67,910 in total drug cost. In 2023, CMS named 489 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Sirichotiratana for performance year 2024, reported as part of a group. Dr. Sirichotiratana accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,185 procedures of removal of skin lesions by Dr. Sirichotiratana, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Sirichotiratana in 2011. 2011 was the busiest year, with 2. Dr. Sirichotiratana's most frequent co-authors are Cloyce L. Stetson, MD, Matthew R. Donaldson, MD and Megan Phillips Lent, MD.

Dmand AI links Dr. Sirichotiratana to 1 clinical trial. Conditions studied include Cellulite and Skin Manifestations. Open Payments lists research payments to Dr. Sirichotiratana that name 1 trial.

CMS Open Payments shows 523 general payments to Dr. Sirichotiratana from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Abbvie Inc. paid the most, $2,401. It also lists 8 research payments totaling $1,720 in 2018, naming 1 clinical trial.

Dr. Sirichotiratana graduated from Loma Linda University School Of Medicine in 2011.

Dr. Sirichotiratana is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.